Case 3: personalised pharmacological treatment of T2DM to minimise cardiovascular disease risk

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: Challenges and opportunities: cardiovascular disease (CVD) prevention in patients with type 2 diabetes Diabetes and the Heart EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

ESC 365 is supported by

ESC 365 is supported by